# Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM

> **NCT03283631** · PHASE1 · TERMINATED · sponsor: **Gary Archer Ph.D.** · enrollment: 2 (actual)

## Conditions studied

- Recurrent Glioblastoma
- Recurrent Gliosarcoma

## Interventions

- **BIOLOGICAL:** EGFRvIII-CARs

## Key facts

- **NCT ID:** NCT03283631
- **Lead sponsor:** Gary Archer Ph.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-30
- **Primary completion:** 2019-09-19
- **Final completion:** 2020-06-30
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** We are halting enrollment of this study.
- **Last updated:** 2021-04-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03283631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03283631, "Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03283631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*